J. Robert Coleman

Company: HERVolution Therapeutics

Job title: Chief Executive Officer

Seminars:

Equipping Efficient Target Selection to Spearhead Favorable Efficacies 2:30 pm

Determining beneficial target properties to predict effective target profiles Considering your drug modality and delivery method and how this may impact targeting ability Comparing potential functional efficacy to prioritize beneficial targets among large numbers of potential targetsRead more

day: Day 1

Pioneers’ Panel: Shedding a Light on the Value of the Dark Genome to Raise Awareness & Educate the Wider Community 8:30 am

Highlighting the vast potential of the dark genome across a range of disease indications to grow appreciation for targeted therapeutics Discussing common investor concerns and how to address these to promote funding in the field How can we demonstrate proof of concept and improved standard of care for dark genome therapeutics?Read more

day: Day 1